Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil.
Varkevisser CM, Lever P, Alubo O, Burathoki K, Idawani C, Moreira TM, et al.. Leprosy review. 2009; 80(1):65-76.
A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota B, Shrestha K, Pandey B, Walker SL. Leprosy review. 2008; 79(4):425-8.
Leprosy scenario in Nepal.
Jain MC. JNMA; journal of the Nepal Medical Association. 2008; 47(172):259-63.
Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M, Brandsma WJ, Faber WR, Bhattarai B, Feuth T, Anderson AM. Leprosy review. 2008; 79(3):254-69.
Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Pandey B, Shrestha K, Lewis J, Hawksworth RA, Walker SL. Tropical doctor. 2007; 37(3):162-3.
Skin disease is common in rural Nepal: results of a point prevalence study.
Walker SL, Shah M, Hubbard VG, Pradhan HM, Ghimire M. The British journal of dermatology. 2008; 158(2):334-8.
Leprosy blindness in Nepal.
Gupta H, Shakya S, Shah M, Pradhan H. Nepal Medical College journal : NMCJ. 2006; 8(2):140-2.
Leprosy disease in Nepal : knowledge and non-compliance of patients.
Chalise SC. JNMA; journal of the Nepal Medical Association. 2005; 44(158):39-43.
Transformation of a leprosy hospital in Nepal into a rehabilitation centre: the Green Pastures Hospital experience.
Brandsma JW, Schwarz RJ, Anderson AM, Herm FB. Leprosy review. 2005; 76(4):267-76.
Gender difference in socio-epidemiological factors for leprosy in the most hyper-endemic district of Nepal.
Kumar R, Singhasivanon P, Sherchand J, Mahaisavariya P, Kaewkungwal J, Peerapakorn S, et al.. Nepal Medical College journal : NMCJ. 2004; 6(2):98-105.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.